IMARAD
ActiveSummary
IMARAD has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.09M and a net result of €288k. Equity is growing by ~6.9% per year across the filed fiscal years. Its solvency ranks better than 64% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability88▲+18
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 4.11 against 16.03 in 2024; short-term debt: 24% and cash: 61.8% of total assets), and 24% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76%
Return on assets
20.2%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 17-01-2026, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
14 d early
2024
53 d early
2022
23 d late
2021
22 d late
2020
23 d late
2019
28 d late
2018
26 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
History
Financials · fiscal year 2025, micro schema
Equity
€1.09M▲ 2.5%
2024 · €1.06M
Total assets
€1.43M▲ 26.8%
2024 · €1.13M
Net result
€288k▲ 19.4%
2024 · €241k
Working capital
€1.07M▲ 3.8%
2024 · €1.03M
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220242025
Operating result€208k▼ 3.1%€236k▲ 13.5%€231k▼ 2.1%€532k-€506k▼ 4.7%
Net result€117k▲ 13.6%€130k▲ 11.1%€106k▼ 18.6%€241k-€288k▲ 19.4%
Equity€891k▲ 15.0%€713k▼ 19.9%€818k▲ 14.7%€1.06M-€1.09M▲ 2.5%
Total assets€918k▲ 12.4%€751k▼ 18.3%€834k▲ 11.1%€1.13M-€1.43M▲ 26.8%
Debt€27k▼ 35.5%€37k▲ 35.5%€16k▼ 58.1%€68k-€344k▲ 402%
Working capital€804k▲ 23.8%€645k▼ 19.8%€770k▲ 19.4%€1.03M-€1.07M▲ 3.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.43M
Fixed assets
€18k ▼ 40.2%
Current assets
€1.41M ▲ 28.6%
Equity and liabilities €1.43M
Equity
€1.09M ▲ 2.5%
Debt
€344k ▲ 402%
Debt's share of the balance-sheet total rises from 6.1% to 24.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€520k▼
2024 · €554k
Cash flow
€302k▲
2024 · €263k
Current ratio
4.11▼
2024 · 16.03
Debt to equity
0.32▲
2024 · 0.06
ROE
26.5%▲
2024 · 22.8%
ROA
20.2%▼
2024 · 21.4%
Interest coverage
5.29▲
2024 · 2.96
Debt ≤ 1 year
€344k▲
2024 · €68k
Income taxes
€135k▲
2024 · €111k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €43k | €29k | €23k | €22k | €14k | ▼ 37.8% |
| Other operating charges640/8 | - | €1k | €77k | €3k | €1k | ▼ 46.6% |
| Gross operating margin9900 | €254k | €266k | €331k | €556k | €522k | ▼ 6.2% |
| Operating profit (loss)9901 | €208k | €236k | €231k | €532k | €506k | ▼ 4.7% |
| Financial income75/76B | - | €23k | €513 | €8k | €15k | ▲ 80.6% |
| Recurring financial income75 | €6k | €23k | €513 | €8k | €15k | ▲ 80.6% |
| Financial charges65/66B | - | €71k | €77k | €187k | €98k | ▼ 47.5% |
| Recurring financial charges65 | €46k | €71k | €77k | €187k | €98k | ▼ 47.5% |
| Profit (loss) for the period before taxes9903 | €168k | €187k | €155k | €352k | €423k | ▲ 19.9% |
| Income taxes67/77 | €51k | €57k | €49k | €111k | €135k | ▲ 21.1% |
| Profit (loss) for the period9904 | €117k | €130k | €106k | €241k | €288k | ▲ 19.4% |
| Profit (loss) for the period to be appropriated9905 | €117k | €130k | €106k | €241k | €288k | ▲ 19.4% |
| Line | 2020 | 2021 | 2022 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €918k | €751k | €834k | €1.13M | €1.43M | ▲ 26.8% |
| Fixed assets21/28 | €87k | €69k | €49k | €30k | €18k | ▼ 40.2% |
| Intangible fixed assets21 | €62k | €42k | €29k | €19k | €11k | ▼ 42.6% |
| Tangible fixed assets22/27 | €24k | €26k | €20k | €11k | €7k | ▼ 35.9% |
| Furniture and vehicles24 | - | €18k | €13k | €6k | €4k | ▼ 35.0% |
| Other tangible fixed assets26 | - | €8k | €6k | €5k | €3k | ▼ 37.0% |
| Financial fixed assets28 | €185 | €185 | €185 | - | - | - |
| Current assets29/58 | €832k | €682k | €785k | €1.10M | €1.41M | ▲ 28.6% |
| Amounts receivable within one year40/41 | €2k | €2k | €4k | €10k | €10k | ▲ 0.3% |
| Trade receivables40 | - | €2k | - | - | - | - |
| Other amounts receivable41 | - | - | €4k | €10k | €10k | ▲ 0.3% |
| Current investments50/53 | €320k | €155k | €147k | €630k | €407k | ▼ 35.5% |
| Cash at bank and in hand54/58 | €394k | €487k | €585k | €457k | €884k | ▲ 93.2% |
| Deferred charges and accrued income490/1 | - | €38k | €50k | €551 | €111k | ▲ 20,101% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €918k | €751k | €834k | €1.13M | €1.43M | ▲ 26.8% |
| Equity10/15 | €891k | €713k | €818k | €1.06M | €1.09M | ▲ 2.5% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Outside capital11 | - | €19k | €19k | €19k | €19k | = |
| Other1109/19 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €872k | €695k | €800k | €1.04M | €1.07M | ▲ 2.6% |
| Non-distributable reserves130/1 | - | €21k | €21k | €21k | €21k | = |
| Reserves not available under the articles1311 | - | €21k | €21k | €21k | €21k | = |
| Distributable reserves133 | - | €673k | €778k | €1.02M | €1.05M | ▲ 2.6% |
| Amounts payable17/49 | €27k | €37k | €16k | €68k | €344k | ▲ 402% |
| Amounts payable within one year42/48 | €27k | €37k | €16k | €68k | €344k | ▲ 402% |
| Trade debts44 | €371 | €837 | €2k | €7k | €7k | ▲ 5.6% |
| Suppliers440/4 | - | €837 | €2k | €7k | €7k | ▲ 5.6% |
| Taxes, remuneration and social security45 | - | €18k | €4k | €59k | €79k | ▲ 34.0% |
| Taxes450/3 | - | €18k | €4k | €59k | €79k | ▲ 34.0% |
| Other amounts payable47/48 | - | €19k | €9k | €3k | €257k | ▲ 10,094% |
| Line | 2020 | 2021 | 2022 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €117k | €130k | €106k | €241k | €288k | ▲ 19.4% |
| + Depreciation and write-downs630 | €43k | €29k | €23k | €22k | €14k | ▼ 37.8% |
| Operating cash flow (approximation) | €160k | €158k | €129k | €263k | €302k | ▲ 14.6% |
| Investment in fixed assets (approximation) | - | €-11k | €-3k | - | €-2k | - |
| Change in cash | - | €92k | €98k | - | €426k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Highest result since 2018net €288k ▲19.4%
Net result €288k, the highest in the series.
2024
09-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
30-06
Financial
Equity above €1MEq €1.06M ▲29.4%
6 profitable years in a row build equity to €1.06M.
2023
23-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 23 days late
2022
31-12
Financial
Liquidity triplescurrent ratio 50.43
Current ratio from 18.34 to 50.43; short-term debt falls from €37k to €16k.
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 22 days late
2021
23-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 23 days late
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 28 days late
2019
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 26 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
19-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 19 days late
2016
08-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2003
Ground area
279 m²
Building footprint
118 m²
Volume, LiDAR
1,689 m³
Parcel 21447B0140/00R002, Brussels · tallest building 18.7 m, ±5 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Abdijstraat 61, 1050 Elsene
since 20032.270.273.023
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0140/00R002 | Brussels | 279 m² | 1 · 118 m² | 18.7 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300B8WBPO1251L349
Similar companies · same sector, comparable size
B.D. RAD
BE 0753.473.333
Kuurne · Eq €1,076,722
HUISARTSENPRAKTIJK H & G
BE 0820.864.775
Geel · Eq €1,095,293
DR. VEERLE PROVOOST, RADIOLOGIE
BE 0876.721.830
Leuven · Eq €1,096,836
MEDISCHE BEELDVORMING ZELZATE
BE 0461.789.284
Zelzate · Eq €1,097,987
Dr. Heide De Haene, klinisch bioloog
BE 0875.808.644
Gent · Eq €1,072,561
Of 699 companies in sector 86910 we hold annual accounts for 521. 385 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-07-2003
Fiscal year end30-06
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
Scores and ratios are computed by Checked and are not a credit decision.